Kai BioTech Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Employees
  • 13

Employees

  • Latest Deal Type
  • IPO

Kai BioTech General Information

Description

KaiBioTech Co Ltd develops and supplies radiopharmaceuticals, dementia diagnosis drugs, and liver cancer drugs.

Contact Information

Website
www.kaibiotech.com
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • 20 Geonji-ro
  • Deokjin-gu, Jeollabuk-do
  • Jeonju-si, 54907
  • South Korea
+82
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Vertical(s)
Oncology
Corporate Office
  • 20 Geonji-ro
  • Deokjin-gu, Jeollabuk-do
  • Jeonju-si, 54907
  • South Korea
+82

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Kai BioTech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. IPO 23-Dec-2022 Completed Generating Revenue
1. Early Stage VC 06-Sep-2016 Completed Generating Revenue
To view Kai BioTech’s complete valuation and funding history, request access »

Kai BioTech Patents

  • 3

    Total Documents Applications and Grants

  • Total Patents Families

  • 1

    Granted

  • Pending

  • Expiring in next 12 mo

Kai BioTech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2021153823-A1 Method for preparing chitosan hydrogel-chelator for cancer therapy Inactive 30-Jan-2020
US-20090304586-A1 Chelating agent conjugated alpha-msh peptide derivatives, preparation method thereof and composition for diagnosis and treatment of melanoma comprising the same as an active ingredient Active 26-Mar-2008
US-8124054-B2 Chelating agent conjugated α-msh peptide derivatives, preparation method thereof and composition for diagnosis and treatment of melanoma comprising the same as an active ingredient Inactive 26-Mar-2008 C07K14/685

Kai BioTech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial

Kai BioTech ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Pharmaceuticals

Subindustry

Rank

Percentile

To view Kai BioTech’s complete esg history, request access »

Kai BioTech FAQs

  • When was Kai BioTech founded?

    Kai BioTech was founded in 2012.

  • Where is Kai BioTech headquartered?

    Kai BioTech is headquartered in Jeonju-si, South Korea.

  • What is the size of Kai BioTech?

    Kai BioTech has 13 total employees.

  • What industry is Kai BioTech in?

    Kai BioTech’s primary industry is Biotechnology.

  • Is Kai BioTech a private or public company?

    Kai BioTech is a Private company.

  • What is Kai BioTech’s current revenue?

    The current revenue for Kai BioTech is .

  • How much funding has Kai BioTech raised over time?

    Kai BioTech has raised $2.69M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process